Metoprolol succinate and Azor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Metoprolol succinate (metoprolol succinate) and Azor (amlodipine besylate; olmesartan medoxomil). Common drug interactions include asthenia among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Metoprolol succinate and Azor. It is created by eHealthMe based on reports of 43 people who take the same drugs from the FDA, and is updated regularly.

What is Metoprolol succinate?

Metoprolol succinate has active ingredients of metoprolol succinate. It is often used in high blood pressure. eHealthMe is studying from 66,933 Metoprolol succinate users. Check the latest studies of Metoprolol succinate.

What is Azor?

Azor has active ingredients of amlodipine besylate; olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 3,922 Azor users. Check the latest studies of Azor.

On Jul, 16, 2026

43 people who take Metoprolol succinate and Azor together, and have interactions are studied.

Metoprolol succinate and Azor drug interactions.

What are the common drug interactions of Metoprolol Succinate and Azor, by gender? *:

female:

Asthenia (weakness)
Dizziness
Fatigue (feeling of tiredness)
Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract)
Pain
Pneumonia
Renal failure (kidney dysfunction)
Arthropathy
Blood cholesterol increased
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)

male:

Death
Chronic kidney disease
Gait disturbance
Gout (uric acid crystals building up in the body)
Hospitalisation
Oedema peripheral (superficial swelling)
Renal failure (kidney dysfunction)
Renal injury (kidney injury)
Stent placement
Type 2 diabetes mellitus

What are the common drug interactions of Metoprolol Succinate and Azor, by age (0-1 to 60+)? *:

0-1:

Asthenia (weakness)
Blood potassium decreased
Constipation
Dehydration (dryness resulting from the removal of water)
Dysgeusia (disorder of the sense of taste)
Fatigue (feeling of tiredness)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood)
Nausea (feeling of having an urge to vomit)
Nephrogenic anaemia (anaemia due to kidney disease)

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Iliac vein occlusion (narrowing of an iliac vein segment between the aortic bifurcation and the groin)
Pelvic pain

50-59:

Diabetes mellitus inadequate control
Diverticulum intestinal (a pouch that is attached to the first part of the small intestine)
Haemorrhoids (a swollen vein or group of veins in the region of the anus)
Irritable bowel syndrome
Lactose intolerance (inability to digest lactose)
Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract)
Polyp
Rectocele (a bulging of the front wall of the rectum into the back wall of the vagina)
Arterial thrombosis (formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system)
Back pain

60+:

Dizziness
Death
Anxiety
Arthropathy
Asthenia (weakness)
Chronic kidney disease
Constipation
Contusion (a type of hematoma of tissue in which capillaries)
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Crying

What are the existing conditions these people have? *

High Blood Cholesterol: 8 people, 18.60%
Primary Myelofibrosis (primary disorder of the bone marrow): 7 people, 16.28%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 7 people, 16.28%
Insomnia (sleeplessness): 4 people, 9.30%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 4 people, 9.30%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 3 people, 6.98%
Stress And Anxiety: 3 people, 6.98%
Pain: 3 people, 6.98%
Irritable Bowel Syndrome: 3 people, 6.98%
Indigestion: 3 people, 6.98%

* Approximation only. Some reports may have incomplete information.

Do you take Metoprolol succinate and Azor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously